Humoral immune responses during a malaria vaccine trial in Tanzanian infants

Galindo, Acosta, Schellenberg, Aponte… - Parasite …, 2000 - Wiley Online Library
The development of a malaria vaccine is a priority for improved and sustained malaria
control. Optimal use of a vaccine in Africa will only be achieved if it can be delivered through …

Humoral immune responses during a malaria vaccine trial in Tanzanian infants

CM Galindo, CJ Acosta, D Schellenberg… - Parasite …, 2000 - pubmed.ncbi.nlm.nih.gov
The development of a malaria vaccine is a priority for improved and sustained malaria
control. Optimal use of a vaccine in Africa will only be achieved if it can be delivered through …

Humoral immune responses during a malaria vaccine trial in Tanzanian infants.

CM Galindo, CJ Acosta, D Schellenberg, JJ Aponte… - 2000 - cabidigitallibrary.org
A trial of the malaria peptide vaccine SPf66 was carried out in infants in southern Tanzania,
where it was given alongside the EPI vaccines (Expanded Programme of Immunization …

Humoral immune responses during a malaria vaccine trial in Tanzanian infants.

CM Galindo, CJ Acosta, D Schellenberg… - Parasite …, 2000 - europepmc.org
The development of a malaria vaccine is a priority for improved and sustained malaria
control. Optimal use of a vaccine in Africa will only be achieved if it can be delivered through …

Humoral immune responses during a malaria vaccine trial in Tanzanian infants.

A Schellenberg - Parasite Immunology, 2000 - search.ebscohost.com
The development of a malaria vaccine is a priority for improved and sustained malaria
control. Optimal use of a vaccine in Africa will only be achieved if it can be delivered through …